Short Interest in BioCorRx Inc. (OTCMKTS:BICX) Expands By 100.0%

BioCorRx Inc. (OTCMKTS:BICX) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 800 shares, an increase of 100.0% from the March 31st total of 400 shares. Based on an average daily trading volume, of 2,800 shares, the days-to-cover ratio is currently 0.3 days.

BioCorRx Stock Performance

BICX remained flat at $0.82 during trading on Friday. 7,500 shares of the company’s stock were exchanged, compared to its average volume of 1,740. BioCorRx has a 1 year low of $0.67 and a 1 year high of $2.22. The company’s 50 day moving average price is $1.02 and its two-hundred day moving average price is $1.07. The stock has a market capitalization of $7.30 million, a P/E ratio of -1.82 and a beta of 0.59.

BioCorRx (OTCMKTS:BICX) last issued its earnings results on Monday, April 1st. The company reported ($0.11) earnings per share for the quarter. The company had revenue of $0.02 million for the quarter.

BioCorRx Company Profile

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.